Offer - Urjas Oil for just ₹ 1 X
Arixtra 7.5 Injection 0.6 Ml is a prescription drug, available for use as Injection. It is typically used for the treatment of Deep Vein Thrombosis. The alternative uses of Arixtra 7.5 Injection 0.6 Ml have also been explained below.
Medical history of the patient along with age and gender determines the dosage of Arixtra 7.5 Injection 0.6 Ml. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Detailed information has been provided in the dosage section.
The side effects typically associated with Arixtra 7.5 Injection 0.6 Ml include Nausea or vomiting, Swelling, Skin Rash. While these are the most often observed Arixtra 7.5 Injection 0.6 Ml side effects, there are can be others also. These have been listed below. Normally, these side effects of Arixtra 7.5 Injection 0.6 Ml are not long lasting and go away when the treatment is finished. If, however, they worsen or do not go away, please speak with your physician.
Arixtra 7.5 Injection 0.6 Ml's effect during pregnancy is Severe and Unknown while nursing. In addition, Arixtra 7.5 Injection 0.6 Ml's effects on the liver, heart and kidney are discussed below in the Arixtra 7.5 Injection 0.6 Ml related warnings section.
Individuals suffering from medical conditions like Bleeding, Endocarditis, Kidney Disease must refrain from the use of Arixtra 7.5 Injection 0.6 Ml since this can cause severe adverse effects. The section on Arixtra 7.5 Injection 0.6 Ml contraindications lists all such conditions.
Drug reaction of Arixtra 7.5 Injection 0.6 Ml with other medicines has been reported. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Arixtra 7.5 Injection 0.6 Ml is considered safe while driving, and is addictive.
Arixtra 7.5 Injection 0.6 Ml is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Arixtra 7.5 Injection 0.6 Ml safe for pregnant women?
Arixtra shows severe side effect on pregnant women. For this reason, pregnant women should only take it after taking medical advice.
Is the use of Arixtra 7.5 Injection 0.6 Ml safe during breastfeeding?
Due to lack of research work on this topic, the side effects of Arixtra for breastfeeding women are not known.
What is the effect of Arixtra 7.5 Injection 0.6 Ml on the Kidneys?
Arixtra may cause harmful effects on kidney. if you feel its having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Arixtra 7.5 Injection 0.6 Ml on the Liver?
Arixtra is rarely harmful for the liver.
What is the effect of Arixtra 7.5 Injection 0.6 Ml on the Heart?
Arixtra is rarely harmful for the heart.
If you are suffering from any of the following diseases, you should not take Arixtra 7.5 Injection 0.6 Ml unless your doctor advises you to do so -
Is this Arixtra 7.5 Injection 0.6 Ml habit forming or addictive?
No, there is no any evidence that Arixtra 7.5 Injection 0.6 Ml is addictive.
Is it safe to drive or operate heavy machinery when consuming?
Arixtra 7.5 Injection 0.6 Ml will not make you feel sleepy or drowsy. So you drive or operate machinery safely.
Is it safe?
Yes, but consume Arixtra 7.5 Injection 0.6 Ml only on doctor's advice.
Is it able to treat mental disorders?
No, Arixtra 7.5 Injection 0.6 Ml is not used to treat mental disorders.
Interaction between Food and Arixtra 7.5 Injection 0.6 Ml
There isn't any research available on the side effects of taking Arixtra 7.5 Injection 0.6 Ml with food.
Interaction between Alcohol and Arixtra 7.5 Injection 0.6 Ml
No research has been done on this till date. Therefore, it is not known what the effect of taking Arixtra 7.5 Injection 0.6 Ml with alcohol will be.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Arixtra® (fondaparinux sodium)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 619-620
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 593-595